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Abstract
Retinoic acids (RAs) modulate growth, differentiation, and apoptosis in normal, pre-malignant & malignant cells. In the present study, the effects
of RA isomers (all-trans RA, 13-cis RA, and 9-cis RA) on the cell signal transduction of human breast cancer cells have been studied. The relationship
between RAs and an enzymatic antioxidant system was also determined. Estrogen-receptor (ER) positive MCF-7 and ER-negative MDA-MB-231 
human breast cancer cells were treated with different doses of each RA isomers, all-trans RA, 13-cis RA, or 9-cis RA. Treatment of RA isomers
inhibited cell viability and induced apoptosis of MCF-7 cells as a result of increased caspase activity in cytoplasm and cytochrome C released
from mitochondria. All-trans RA was the most effective RA isomer in both cell growth inhibition and induction of apoptosis in MCF-7 cells. However,
no significant effect of RA isomers was observed on the cell growth or apoptosis in ER-negative MDA-MB-231 cells. In addition, activities of
antioxidant enzymes such as catalase and glutathione peroxidase were decreased effectively after treatment of RA in MCF-7 cells, whereas SOD
activity was rarely affected. Thus, the present data suggest that all-trans RA is the most potential inducer of apoptosis and modulator of antioxidant
enzymes among RA isomers in MCF-7 human breast cancer cells. 
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Introduction1)
Among the many investigations of breast cancer, there has been 
much interest recently in retinoic acid (RA) metabolites used in 
i) cellular growth process, ii) activating gene transcription by 
specific nuclear receptors, iii) inhibiting cancer cell growth by 
several different pathways (Freemantle et al., 2003; Marill et al., 
2003; Napoli, 1996; Ralhan & Kaur, 2003; Smith et al., 1992). 
Previous studies also suggest an intimate relationship between 
cancer and serum RA level; possibly in prevention of cancer 
cell proliferation or development into second malignancy in 
breast and liver cancer (Gronemeyer & Miturski, 2001; Manor 
et al., 2003; Prakash et al., 2001). Treatment with RA in other 
types of cancer, ischemia or pathophysiology of acne has been 
shown to be effective as well (Brodowicz et al., 1999; Freemantle 
et al., 2003; Nelson et al., 2006; Sato et al., 2008). Many studies 
have been conducted on molecular and cellular mechanisms of 
RA in the past ten years. In particular, the roles of RA in control 
and gene expression of cancer cell’s initiation and apoptosis, in 
multiple signal pathways inside cancer cells, and in the 
correlation between cancer cells and RA receptors have been 
investigated (Chambon, 1996; Hayashi et al., 2001; Marill et al., 
2003).
  However, recent clinical experiments that used RA show 
no effect in reducing first stage or second stage lung cancer for 
cigarette smokers. In addition, due to the potential toxicity of 
RA, detailed research is needed on the effect of physiological 
dose of RA through a close examination of its mechanisms at 
the cellular level (Freemantle et al., 2003; Ralhan & Kaur, 2003; 
Windhorst & Nigra, 1982). 
When free radicals and reactive oxygen species (ROS) 
accumulate in the process of aerobic cell metabolism, it 
consequently results in diseases and aging by inducing damage 
to tissues and cells. ROS are also known to be involved in cancer 
growth, cancer cell regeneration and differentiation, and cell 
signaling systems (Drisko et al., 2003). The enzymatic defense 
mechanisms with superoxide dismutase (SOD), catalase, and 
glutathione peroxidase participate in converting superoxide anion 
to H2O2, and then to H2O. Although turnover volume for catalase 
is very high, its affinity to H2O2 is relatively low. Therefore, 
when H2O2  accumulates in cells in even low concentration, it 
can cause oxidative damage to DNA, which then induces cancer 
or cell death (Nordberg & Arner, 2001). According to studies 
of relationship between RA and antioxidation, RA stabilizes 
protein levels in brain cells and the activity of SOD at the mRNA 
level, thereby reduces oxidative stress and apoptosis (Ahlemeyer 
et al., 2001). On the other hand, according to other researches, 
among RA isomers, all-trans RA suppresses cell growth of 
malignant myeloblastic leukemia and induces its apoptosis, and 
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is known to control the activity levels of antioxidant enzymes 
in rat sertoli cells. Many different aspects of cellular level 
mechanisms of RA are currently being discovered. However, 
inconsistency of the results requires more in-depth research 
(Conte da Frota et al., 2006; Xu et al., 2002).
In this report, we have investigated to measure the influence 
of RA isomers (all-trans RA, 13-cis RA, and 9-cis RA) on 
apoptosis and on enzymatic antioxidant system in breast cancer 
cell lines using the activity levels of caspases and antioxidant 
enzymes.
Materials and Methods
Chemicals and reagents
All-trans RA, 13-cis RA, and 9-cis RA were purchased from 
Sigma Chemical Co. (St. Louis, MO). Growth media RPMI-1640 
and other growth supplements, heat-inactivated fetal bovine 
serum (FBS), penicillin streptomycin, Hank’s Balanced Salt 
Solutions (HBSS) were obtained from Gibco-BRL (Eggenstein, 
Germany). A spectrophotometric assay kit for SOD activity and 
a colormetric kit for apoptosis were purchased from R&D 
Systems (Wiesbaden, Germany). Caspase-8&-9 fluorescent assay 
kits were purchased from Peptron Co. (Daejeon, Korea). 
Cell culture and treatment of cells
Human breast ER-positive cells MCF-7 and ER-negative cells 
MDA-MB-231 obtained from the American Type Culture 
Collection (Rockville, MD) were grown in Roswell Park 
Memorial Institute (RPMI) medium-1640 containing HEPES, 
sodium bicarbonate, penicillin streptomycin, and 10% fetal 
bovine serum at 37℃ in a humidified atmosphere of 5% CO2 
in  air. Around 80% confluent cells were passaged by standard 
trypsinization procedures. Cells were seeded at a density of 3x10
4 
cells /P-100 dish. The RA isomer solutions dissolved in ethanol 
(final ethanol concentration was 0.1%) were diluted in culture 
medium to final concentrations of 10, 100, and 1,000 nM. Cells 
were treated for up to 4 days. All solutions containing RA 
isomers were handled under yellow light. The range of RA 
concentration was 10 nM∼1  μM. Considering the potential 
toxicity and resistance of retinoic acid, the concentration over 
1 μM was not used. Media in the presence and absence of RA 
isomers were changed every 48 hrs and cells were harvested and 
counted with a haemocytometer. Each sample was counted in 
duplicate, and each experiment was done in triplicate (Prakash 
et al., 2001). 
MTT assay
Following incubation with various reagents, the rate of cell 
viability was assessed by colormetric measurement of 3-[4,5- 
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) 
reduction (Rishi et al., 2003). Values from each treatment were 
calculated as a percentage relative to the untreated control 
(defined as 100% survival).
Apoptosis detection assay
MCF-7 and MDA-MB-231 cells placed in dishes filled with 
3.7% buffered formaldehyde solution for 7 min. at room 
temperature (RT) were washed twice with 1X PBS. The cells 
were post-fixed in 100% methanol for 20 min and washed twice 
with 1X PBS. A portion of 50 μl of cytonin solution was added 
to each dish and the cells were incubated for 15 min at RT. 
Fixed cells were washed with 200 μl of DNasa-free water, to 
which 50 μl of 2.5% H2O2  solution was added and the cells were 
incubated for 5 min at RT. After washing the cells again, 150 
μl of 1X TdT labeling buffer was added, and the cells were 
incubated for 5 min. The cells were washed, and 50 μl of labeling 
reaction mixture was added followed by incubation at 37℃ for 
1 hr. The cells were placed in 150 μl of 1X TdT stop buffer 
for 5 min and washed twice with 1X PBS for 2 min. The cells 
were placed in 50 μl of streptavidin-HRP solution and incubated 
at RT for 10 min. Cells were washed four times with 200 μl 
of PBS and 0.1% Tween 20. The cells were then placed in 100 
μl of TACS-Sapphire and incubated at RT for 30 min in the 
dark. The reaction was stopped by adding 100 μl of 2N HCl. 
The absorbance of apoptotic cells, which could be detected by 
labeling of terminal deoxynucleotidyl transferase (TdT) and 
TACS-Sapphire, was measured at 450 nm (Kuypers et al., 1996; 
Pigault  et al., 1994) 
Caspase activity assay 
To determine caspase-3 activity, western blot analysis (Nelson 
et al., 2006) was used. Fluorometiric assay was used to measure 
activities of caspase-8 &-9 (Kuida, 2000; Stennicke & Salvesen, 
2000; Villa et al., 1997). 
Determination of cytochrome C releasere 
The release of cytochrome C into the cytosol of MCF-7 cells 
treated with 1 μM of RA isomers for 4 days was measured by 
a western blot (Nagase et al., 2001) For the detection of 
cytochrome C, the lysate from the last centrifugation and 
mitochondrial fractions were subjected to 12% SDS-PAGE. 
Proteins in the gel were transferred onto prewetted polyvinylidene 
difluoride (PVDF)- nitrocellulose filters (Bio-Rad, Cambridge, 
MA). Membranes were blocked with 5% non-fat, dry milk in 
TBST at RT for 1hr to reduce nonspecific antibody binding. 
Membranes were washed with PBS three times and incubated 
with cytochrome C specific antibody. Specific bands of interest 
were detected by Enhanced Chemiluminescence (ECL; 
Amersham, Buckinghamshire, U.K.).Tae-Kyong Hong and Yang Cha Lee-Kim 79
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Fig. 1. Effect of retinoic acid (RA) isomer concentrations on the growth of 
human breast cancer MCF-7 cells (A) and MDA-MB-231 cells (B). MCF-7 cells 
and  MDA-MB-231  cells  were  seeded  at  3x10
4  cells  and  incubated  with  various 
concentrations of RA isomers for 4 days. The viability of Cells were measured by 
MTT assay. Values are means ± S.D. of three independent experiments. 
＊P<0.05: 
compared  to  the  control
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Fig. 2. Effect of retinoic acid (RA) isomer concentrations on apoptosis of 
human breast cancer MCF-7 cells (A) and MDA-MB-231 cells (B).  Apoptotic 
cells  were  detected  the  most  at  1  μM  all-trans  RA.  Results  are  expressed  as 
relative  %  of  control  value.  Values  are  means ± S.D.  of  three  independent 
experiments.  *p<0.05:  compared  to  the  control  group
Antioxidant enzyme activity assay
Activities of SOD, catalase and glutathione peroxidase were 
measured by spectrophotometry (Arruda et al., 1996; Bai et al., 
1999; Sutherland & Learmonth, 1997). 
Statistical analysis
For statistical analysis, each experiment was carried out in 
triplicate sets and the SAS program was used. Data were 
expressed as mean ± SE. The differences among mean values 
were assessed by one-way analysis of variance (ANOVA) 
coupled with Duncan's multiple range test or student's t test. A 
p-value <0.05 was considered to be statistically significant.
Results 
Effect of RA isomer concentrations on breast cancer cell growth 
In the ER-positive MCF-7 cell line, the cancer cell growth 
was blocked by the high concentration of RA. In particular, 
all-trans RA showed greater inhibition of cancer cell growth than 
other isomers did, showing the lowest cell survival rate of 61% 
at 1 μM concentration. This result was followed by 13-cis RA, 
which showed a 67% cell survival and 9-cis RA resulted in 75% 
survival, which showed the least influence in breast cancer cell 
growth. On the other hand, in the ER-negative MDA-MB-231 
cell line, all-trans RA did show a better suppression of cancer 
cell growth (79% cell survival) than the other isomers similar 
to shown in ER-positive MCF-7 cell line. The effect on cell 
growth inhibition in the ER-negative MDA-MB-231 cells was 
not as significant as in ER-positive MCF-7 cell line (Fig. 1).
Changes in apoptosis by RA isomers
In both ER-positive MCF-7 and ER-negative MDA-MB-231 
cell lines, as the concentration of RA isomers (all-trans RA, 
13-cis RA, and 9-cis RA) became higher, the number of cell 
deaths increased (Fig. 2). All-trans RA in the MCF-7 cell line 
at 1 μM concentration showed the greatest suppression of cancer 
cell growth up to 41%, followed by 13-cis RA up to 37%, and 
9-cis RA up to 28%. In the MDA-MB-231 cell line, the induction 
of apoptosis was considerably lower, with all-trans RA showing 
18% cell death, 13-cis RA showing 16%, and 9-cis RA showing 
11% (Fig. 2). These results indicate that RA isomers are closely 
related to sensitivity and resistance of breast cancer cells. 
According to several research results, the ER positive breast 
cancer cells are known to be related to sensitivity of breast cancer 
cells due to RA, and exert influence on cell growth inhibition, 
while ER-negative breast cancer cells are reported to have more 
effect on cells’ resistance than on sensitivity (Freemantle et al., 
2003; Gallagher, 2002).
Changes in caspase-3 activity and inhibition by RA isomers 
The effect of RA isomers on cell death of the ER-positive 
MCF-7cell line was the maximum at 1 μM of RA isomers. 
Examining with a western blot, the changes in the activity of 80 Retinoic acid isomers and breast cancer cells
Caspase-3 
Actin 
Control  All-trans RA  13-cis RA  9-cis RA
Fig. 3. Effect of retinoic acid (RA) isomers on caspase-3 activity in MCF-7 cells.
MCF-7 cells were seeded at 3x10
4 cells and incubated with 1 μM RA isomers. 
Caspase-3  activity  was  measured  by  a  Western  blot  using  caspase  cleavage 
specific  antibody.
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Fig. 4. Effect of all-trans retinoic acid (RA) on caspase inhibiton of MCF-7 cells.
MCF-7  cells  were  seeded  at  3x10
4cells  and  incubated  with  1  μM  all-trans  RA. 
Caspase inhibitor was used by Ac-DEVD-CHO. A: Caspase-3 activity by caspase 
inhibitor  in  ER-positive  MCF-7  cells.  B:  Effect  of  caspase  inhibitor  on  viability  of 
MCF-7 cells. Results are expressed as relative % of control value. Values are means
± S.D.  of  three  independent  experiments.  *p<0.05,  **p<0.01:  compared  to  the 
control  group
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Fig. 5. Effect of retinoic acid (RA) isomers on cytochrome C release from 
mitochondria in MCF-7 cells. MCF-7  cells  were  seeded  at  3x10
4  cells  and 
incubated  with  1uM  RA  isomers.  Released  cytochrome  C  was  measured  by  a 
Western blot. Actin was a protein marker that sould not change between samples.
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Fig. 6. Effect of retinoic acid (RA) isomers on caspase -8 (A) & -9 (B) activities 
in MCF-7 cells.  MCF-7  cells  were  seeded  at  3x10
4  cells  and  incubated  with  1 
μM RA isomers. All-trans RA was the most effector of RA isomers. The activities 
of  caspase-8  &-9  were  measured  by  using  fluorogenic  substrates  Ac-IETD-AMC 
(caspase-8) and Ac-LEHD-PNA (caspase-9). Results are expressed as relative % 
of  activities  of  caspase-8  &-9.  Values  are  means ± S.D.  of  three  independent 
experiments.  *p<0.05:  compared  to  the  control  group
caspase-3, which can be the major effector inducing apoptosis, 
showed that all-trans RA increased caspase-3 activity most 
significantly compared to controls, and it was followed by 13-cis 
RA and 9-cis RA (Fig. 3). To verify the effect of RA on the 
increase of caspase-3 activity, an experiment was carried out in 
which caspase-3 inhibitor, Ac-DEVD-CHO, was treated with 
all-trans RA to determine whether the increase in caspase-3 
activity could be blocked (Fig. 4). In addition, to find out whether 
it sped up the cancer cell growth again, the viability of MCF-7 
cells was measured. The results showed that the cancer cell 
growth was increased again from 40% to 76% when cells were 
treated with caspase-3 inhibitor, Ac-DEVD-CHO (Fig. 4). 
Changes in Cytochrome C release in mitochondria by RA isomers
Cytochrome C release in mitochondria was measured using 
a western blot. The results showed that all-trans RA exerted the 
most influence on the cytochrome C release, similar to the results 
for caspase-3 activity. However, 9-cis RA and 13-cis RA released 
cytochrome C in mitochondria, more so with 9-cis RA than with 
13-cis RA. This indicates that in programmed cell death, RA 
isomers act differently in mechanisms of apoptosis (Fig. 5).
Changes in caspase-8 and caspase-9 activities by RA isomers 
For inducing apoptosis, pro-caspase-8 of the death receptors 
is activated first followed by other caspases activations resulted Tae-Kyong Hong and Yang Cha Lee-Kim 81
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Fig. 7. Effect of retinoic acid (RA) isomers on antioxidant defense enzymes 
of MCF-7 cells. MCF-7  cells  were  seeded  at  3x10
4  cells  and  incubated  with  1 
μM  RA  isomers.  SOD  activites  did  not  show  a  significant  change,  but  catalase 
&  GPx  activities  decreased  the  most  by  all-trans  RA.  Results  are  expressed  as 
relative  %  of  enzymes'  activities.  Values  are  means ± S.D.  of  three  independent 
experiments.  *p<0.05,  **p<0.01:  compared  to  the  control  group
in caspase cascade. In consistent with other studies, all-trans RA 
treatment resulted in a four-fold increase in the caspase-8 activity 
in the MCF-7 cell line. It is plausible that the activation of 
caspase-3 by all-trans RA arises from the increase in the activity 
of caspase-8, which is acting as an initiator of apoptosis. The 
activation of caspase-3 affects the death-receptor pathway 
resulted in apoptosis induction (Fig. 6). Furthermore, cytochrome 
C released in mitochondria (which can be called a key regulator 
of caspase cascade) combines with Apaf-1 and pro-caspase-9 to 
form apoptosome, which can activate caspase-3. All-trans RA 
treatment induced, like other caspase activities, the highest 
increase in the capase-9 activity of mitochondrial pathway, where 
apoptosis pathway advances. This result may be connected with 
cytochrome C being released in mitochondria. All-trans RA 
seems to activate both of the two main pathways that induce 
apoptosis and thus induce cell death.
Changes in the activities of SOD, catalase, and glutathione 
peroxidase by RA isomers
The treatment of RA isomers (all-trans RA, 13-cis RA, and 
9-cis RA) at 1 μM concentration in ER-positive MCF-7 cells 
showed no significant difference in the activity of antioxidant 
enzyme SOD as compared to those of control (Fig. 7). On the 
other hand, when all-trans RA was treated, the catalase activity 
showed 75% of the control value. 9-cis RA caused only a 12% 
difference with that of the control (Fig. 7). The activity of 
glutathione peroxidase showed no significant difference among 
RA isomer treatments. In the case of all-trans RA, the activity 
of glutathione peroxidase was decreased 18% as compared to 
that of the control.
Discussion
Many studies have uncovered therapeutic abilities of RA in 
breast cancer by either blocking cancer regeneration or inducing 
cancer apoptosis (Freemantle et al., 2003; Marill et al., 2003). 
Although scientists have focused on molecular and cellular 
mechanisms of RA for the last decade, research on RA’s multiple 
signal pathways is still scarce. The current study focused on the 
effect of RA isomers (all-trans RA, 13-cis RA, and 9-cis RA) 
on the cell growth and cell death in breast cancer cell lines, 
ER-positive MCF-7 cells and ER-negative MDA-MB-231 cells, 
as well as on the effect of antioxidant systems in the cell lines. 
In ER-positive MCF-7 cell line, as the concentration of RA 
isomer treatment increased, the growth of cancer cells was 
inhibited as compared to that of the control. All-trans RA 
specifically displayed the most significant suppression of cancer 
cell growth over the other isomers. While all-trans RA showed 
stronger suppression of cancer cell growth than the other isomers 
in ER-negative MDA-MB-231 cell line similar to the effect on 
the ER-positive MCF-7 cell line, it produced a higher cell 
survival rate than that of 9-cis RA in ER-positive MCF-7cell 
line. It has been reported that breast cancer is closely related 
to the influence of hormones and cancer cell growth shows 
significant differences depending on the protein binding affinity 
of hormone receptors (Hara et al., 2000; Marill et al., 2003; 
Napoli, 1996; Ott & Lachance, 1979; Paik et al., 2003; Soprano 
et al., 2004). ER-positive breast cancer cells are known to 
respond more sensitively to RA isomers in their inhibition of 
cancer cell growth in contrast to ER-negative breast cancer cells, 
which are known to influence cancer cell resistance (Gallagher, 
2002; Nagpal & Chandraratna, 2000; Xu et al., 1999).
The current study indicated that the inhibition of breast cancer 
cell growth was associated with apoptosis as shown in the MCF-7 
cell line where all-trans RA induced the highest level of 
apoptosis, followed by 13-cis RA and 9-cis RA. It seemed that 
there was no significant cell death effect in the MDA-MB-231 
cell line. In accordance with the previous study (Prakash et al., 
2001), all-trans RA induced greater apoptosis than the other RA 
isomers in the current study. In normal cells, all-trans RA arrested 
the G1 phase of the cell cycle without apoptosis induction, 
whereas in breast cancer cell line, MCF-7, RA not only arrested 
G0/G1 phases but also induced apoptosis at low concentrations 
(Dietze et al., 2002; Dimberg & Oberg, 2003; Rishi et al., 2003; 
Seewaldt et al., 1995). In addition, it has been reported that RA 
isomers control the Bcl-2 family protein (Pepper et al., 2002; 
Pettersson et al., 2002). Therefore, it is plausible that the effects 
mentioned above seem to be associated with the caspase activities 
and cytochrome C as shown in the current study. RA isomers 
may affect the regulation of Bcl-2 family protein and the release 
of cytochrome C in mitochondria (thus called a key regulator 
of caspase cascade). Cytochorme C combines with Apaf-1 and 
pro-caspase-9 to form apoptosome, which activates caspase-3 
resulted in the activation of the apoptosis pathway. It is 
interesting to note that the current study indicates that RA isomer 
treatments incrase the activities of caspase-9 and -3. Furthermore, 
apoptosis is activated when pro-caspase-8 of the death receptor 
is firstly activated and successively activates other caspases, 82 Retinoic acid isomers and breast cancer cells
thereby activating a caspase cascade. When apoptosis is induced, 
the typical morphological change is known to occur due to the 
division of key cellular protein that results from the caspase 
cascade (Hengartner, 2000). In this study, the morphological 
change was also occurred by treatment of RA isomers (Data not 
shown) and the activity of caspase-8 was also increased in breast 
cancer cells. Caspases involved in apoptosis are known to be 
largely classified as initiator caspase-2, -8, -9, -10 and effector 
caspase-3, -6, -7 (Hengartner, 2000; Melino et al., 1997). Overall, 
the results obtained from the current study by treating RA isomers 
(all-trans RA, 13-cis RA, and 9-cis RA) in estrogen receptor (ER) 
positive MCF-7 cell line verify that caspase-8, -9, and -3 are 
acting as initiator and main effectors thereby inducing apoptosis, 
that cytochrome C derived and released in mitochondria also has 
influence, and that all-trans RA showed the most significant 
influence among the RA isomers.
Regarding the effect of RA isomers on antioxidant systems, 
low concentrations of RA (0.1-100 nM) did not show any effect 
on the activity of antioxidant enzymes, whereas high 
concentrations (1-10 μM) controlled the activity of antioxidant 
enzymes (Conte et al., 2006). Furthermore, in the neuronal 
apoptosis case, RA is reported to help the antioxidant system 
by enhancing the protein levels of SOD-1 (cytosolic Cu-& 
Zn-SOD) and SOD-2 (Mn-SOD), and reducing the concentration 
of ROS within cells (Ahlemeyer et al., 2001). In this paper, 
however, RA isomers did not show any effect on the SOD 
activity in breast cancer cells, which implied no differences in 
the protein levels of SOD. In addition, 1 μM of all-trans RA 
concentration showed differences in the activities of catalase and 
glutathione peroxidase while showing no difference in the 
activity of SOD. These observations led to the hypothesis that 
manipulation of cellular redox state may modulate caspase- 
mediated death. By using the ratio of SOD and catalase & GPx, 
H2O2  can be assumed to be accumulated in the breast cancer 
cells treated with all-trans RA. Even if H2O2  concentration in 
cells is a small molar concentration such as 10 μM, it nevertheless 
can induce apoptosis and activates caspase-3, which acts as the 
main effector of the cell death program (Raloff, 2000; Ueda et 
al., 2002) contributing to apoptosis induction. The release of 
cytochrome C into the cytosol by oxidative stress can also 
stimulate the increase of caspase-3 activity in intracellular level 
and regulate the apoptosis process (Ott et al., 2007).
In conclusion, all-trans RA among RA isomers may be the 
most potential inducer of apoptosis and modulator of antioxidant 
enzymes in ER-positive MCF-7 human breast cancer cells.
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